2. UroToday Home
  3. Video Lectures

Prostate Cancer Genomic Classifier Videos

Integrating the Use of Prostate Genomic Classifiers into Clinical Practice - A Clinical Pathway Approach - Katie Murray and Anne Lizardi-Calvaresi
January 30, 2023
Details
Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER Genomic Classifier for Prostate Cancer - Ashley Ross
January 24, 2023
Details
The Use of Genomics in Unfavorable Intermediate-risk Prostate Cancer - David Morris
December 20, 2022
Details
PORTOS as a Predictive Biomarker to Help Personalize Radiotherapy Dose in the Postoperative Setting, in the SAKK 09/10 Trial - Alan Dal Pra
December 5, 2022
Details
Insights from the STAMPEDE Trial Platform - Marina Parry & Gerhardt Attard
November 1, 2022
Details
The Molecular Biology of Prostate Cancer - Christopher Barbieri
October 28, 2022
Details
An Ancillary Study of the STAMPEDE Trial Assessing the Clinical Qualification of Transcriptome Signatures for Advanced Prostate Cancer Starting ADT +/- Abiraterone Acetate and Prednisolone - Gerhardt Attard
October 3, 2022
Details
Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross
August 7, 2022
Details
Rationale for the Use of Decipher RP Genomic Classifier to Inform Treatment - Ashley Ross
July 31, 2022
Details
The Use of the Decipher Biopsy Test Prior to Prostatectomy - Ashley Ross
July 31, 2022
Details
Decipher Biopsy and Decipher for Prostatectomy in Clinical Practice- Ashley Ross
July 13, 2022
Details
Treatment of Unfavorable Intermediate Risk Prostate Cancer - Ashley Ross, Jason Hafron, and Katie Murray
June 14, 2022
Details
The Benefit of ADT Treatment Intensification With Radiotherapy in Localized Prostate Cancer – Dan Spratt and Amar Kishan
May 24, 2022
Details
The Conundrum of Systemic Salvage Therapy at the Time of Salvage Radiation Therapy - Brandon Mahal
May 18, 2022
Details
The Performance of a Genomic Classifier Score in the Phase 3 SAKK 09/10 in Patients with Biochemical Progression - Alan Dal Pra
April 14, 2022
Details
Validation of Performance of the Decipher Biopsy Genomic Classifier in Intermediate-Risk Prostate Cancer: The Phase III Randomized Trial NRG Oncology/RTOG 0126 – Jeff Michalski
February 24, 2022
Details
The Impact of Decipher Biopsy Testing on Clinical Outcomes in Localized Prostate Cancer – Randy A. Vince Jr.
January 23, 2022
Details
High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack
November 18, 2021
Details
Personalized Hormone Therapy with Post-Operative Radiation Therapy and Validation of the Decipher Genomic Classifier in SAKK 09/10 Trial - Dan Spratt and Alan Dal Pra
August 18, 2021
Details
When to Add ADT to Early or Late Salvage Radiation - Dan Spratt
August 18, 2021
Details
Clinical Case Discussions - "Rising PSA 18 Months Post RP and Timing of Radiotherapy" - Ashley Ross, Alan Dal Pra, and Dan Spratt
August 18, 2021
Details
Prognostic Utility of Decipher® Prostate Genomic Classifier in the SAKK 09/10 Phase III Trial - Alan Dal Pra
June 17, 2021
Details
A Systematic Review of the Decipher® Genomic Classifier in Prostate Cancer - Ashley Ross & Daniel Spratt
February 16, 2021
Details
Validation of a Prognostic Genomic Classifier in Salvage Radiotherapy Prostate Cancer from a Prospective Randomized Trial - Felix Feng
February 22, 2020
Details
Data from the RTOG 9601 Study: Treating Prostate Cancer Patients with Low-Volume Disease - Daniel Spratt
December 31, 2019
Details